Carbidopa is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals,inc.. The primary component is Carbidopa.
Product ID | 43386-980_7b3079e3-d9db-41aa-886f-a9f95a828437 |
NDC | 43386-980 |
Product Type | Human Prescription Drug |
Proprietary Name | Carbidopa |
Generic Name | Carbidopa |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2017-10-20 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA204763 |
Labeler Name | Lupin Pharmaceuticals,Inc. |
Substance Name | CARBIDOPA |
Active Ingredient Strength | 25 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2017-10-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA204763 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-10-20 |
Marketing Category | ANDA |
Application Number | ANDA204763 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-10-20 |
Marketing Category | ANDA |
Application Number | ANDA204763 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-10-20 |
Ingredient | Strength |
---|---|
CARBIDOPA | 25 mg/1 |
SPL SET ID: | e95b1ab8-0fd9-4399-897a-5ae73b36af45 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
16714-067 | Carbidopa | Carbidopa |
40032-980 | Carbidopa | Carbidopa |
42799-123 | Carbidopa | Carbidopa |
43386-980 | Carbidopa | Carbidopa |
43975-220 | Carbidopa | Carbidopa |
51407-314 | Carbidopa | Carbidopa |
59651-146 | Carbidopa | Carbidopa |
63629-1932 | Carbidopa | Carbidopa |
63629-9193 | Carbidopa | Carbidopa |
68682-200 | Carbidopa | Carbidopa Tablets |
70710-1221 | CARBIDOPA | CARBIDOPA |
70771-1355 | CARBIDOPA | CARBIDOPA |
25010-711 | Lodosyn | carbidopa |